ConductScience.org, home

Paper39598409

Design, Development and Immunogenicity Study of a Multi-Epitope Vaccine Prototype Against SARS-CoV-2.

Atanasova M and 8 others. Pharmaceuticals (Basel), 2024. Cited by 9 papers, by iCite.

Cite this record

ConductScience Library. Design, Development and Immunogenicity Study of a Multi-Epitope Vaccine Prototype Against SARS-CoV-2. Papers, record 39598409. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39598409

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Design, Development and Immunogenicity Study of a Multi-Epitope Vaccine Prototype Against SARS-CoV-2.
PubMed
Journal
Pharmaceuticals (Basel)
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
1.53, provisional
iCite
Revised in PubMed
2024-11-30
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Atanasova MMariyanahttps://orcid.org/0000-0001-9761-0355
2Dimitrov IIvanhttps://orcid.org/0000-0003-4838-312X
3Ralchev NNikolahttps://orcid.org/0000-0002-9046-5914
4Markovski AAleksandar
5Manoylov IIliyanhttps://orcid.org/0000-0002-8154-8961
6Bradyanova SSilviya
7Mihaylova NNikolinahttps://orcid.org/0000-0001-8582-9296
8Tchorbanov AAndrey
9Doytchinova IIrinihttps://orcid.org/0000-0002-1469-1768

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
KP-06-DK1/2/2021Bulgarian Science FundPubMed
BG05M2OP001-1.001-0003Science and Education for Smart Growth Operational ProgramPubMed
BG05M2OP001-1.002-0001-C04Science and Education for Smart Growth Operational ProgramPubMed
D01-325/2023National Roadmap for Research InfrastructurePubMed

Source PubMed

Download CSV of grants

References47

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132227757Developing Covid-19 Vaccines at Pandemic Speed.N Engl J Med2020https://conductscience.org/library/papers/32227757PubMed
238704475Immunoinformatics design of a structural proteins driven multi-epitope candidate vaccine against different SARS-CoV-2 variants based on fynomer.Sci Rep2024https://conductscience.org/library/papers/38704475PubMed
332473127Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals.Cell2020https://conductscience.org/library/papers/32473127PubMed
432406916NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data.Nucleic Acids Res2020https://conductscience.org/library/papers/32406916PubMed
535594660Design, immunogenicity, and efficacy of a pan-sarbecovirus dendritic-cell targeting vaccine.EBioMedicine2022https://conductscience.org/library/papers/35594660PubMed
620576624EpiTOP--a proteochemometric tool for MHC class II binding prediction.Bioinformatics2010https://conductscience.org/library/papers/20576624PubMed
712589760Crystal structure of MHC class II I-Ab in complex with a human CLIP peptide: prediction of an I-Ab peptide-binding motif.J Mol Biol2003https://conductscience.org/library/papers/12589760PubMed
836352060Bioinformatics approach for the construction of multiple epitope vaccine against omicron variant of SARS-CoV-2.Sci Rep2022https://conductscience.org/library/papers/36352060PubMed
935156709HLA-DR polymorphism in SARS-CoV-2 infection and susceptibility to symptomatic COVID-19.Immunology2022https://conductscience.org/library/papers/35156709PubMed
1016533401EpiJen: a server for multistep T cell epitope prediction.BMC Bioinformatics2006https://conductscience.org/library/papers/16533401PubMed
1136360904HLA Genotypes in Patients with Infection Caused by Different Strains of SARS-CoV-2.Int J Environ Res Public Health2022https://conductscience.org/library/papers/36360904PubMed
1221231985Analysis of HLA-A24-restricted peptides of carcinoembryonic antigen using a novel structure-based peptide-HLA docking algorithm.Cancer Sci2011https://conductscience.org/library/papers/21231985PubMed
1322039305Affinity thresholds for naive CD8+ CTL activation by peptides and engineered influenza A viruses.J Immunol2011https://conductscience.org/library/papers/22039305PubMed
1410733534Chronic viral hepatitis and the human genome.Hepatology2000https://conductscience.org/library/papers/10733534PubMed
1534278794AutoDock Vina 1.2.0: New Docking Methods, Expanded Force Field, and Python Bindings.J Chem Inf Model2021https://conductscience.org/library/papers/34278794PubMed
1634066901Peptide-Based Vaccines: Foot-and-Mouth Disease Virus, a Paradigm in Animal Health.Vaccines (Basel)2021https://conductscience.org/library/papers/34066901PubMed
1735818892The association of human leucocyte antigen (HLA) alleles with COVID-19 severity: A systematic review and meta-analysis.Rev Med Virol2023https://conductscience.org/library/papers/35818892PubMed
1835803932A third vaccination with a single T cell epitope confers protection in a murine model of SARS-CoV-2 infection.Nat Commun2022https://conductscience.org/library/papers/35803932PubMed
1923661105EpiDOCK: a molecular docking-based tool for MHC class II binding prediction.Protein Eng Des Sel2013https://conductscience.org/library/papers/23661105PubMed
2031611696Robust prediction of HLA class II epitopes by deep motif deconvolution of immunopeptidomes.Nat Biotechnol2019https://conductscience.org/library/papers/31611696PubMed

See all 47 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn PapersSource
42746578Reverse vaccinology and immunoinformatics identify multi-epitope vaccine candidates against molluscum contagiosum virus.Biol Methods Protoc2026https://conductscience.org/library/papers/42746578PubMed
42463610Computational structural dynamics and immunoinformatic analysis of EIEC IpaH4.5 targeting immunoprophylaxis design against bacillary dysentery.Mol Divers2026https://conductscience.org/library/papers/42463610PubMed
42288920A protocol for computational design of mRNA vaccines with high functionality and specificity.Biol Direct2026https://conductscience.org/library/papers/42288920PubMed
42115669Domain arrangement-driven immunogenicity of a computationally designed mRNA vaccine targeting PPE68, IrtA, and PE9 of Mycobacterium tuberculosis.Sci Rep2026https://conductscience.org/library/papers/42115669PubMed
40093955The Predictive Value of Soluble Fms-Like Tyrosine Kinase-1 for Prognosis in COVID-19 Patients.J Inflamm Res2025https://conductscience.org/library/papers/40093955PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
ACE259272PubTator's text mininghttps://conductscience.org/library/genes/59272

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39598409

GET https://conductscience.org/api/papers/v1/39598409/references?page=2